The label changes are intended to be used when both the clinician and patient have agreed to reduce the opioid dosage.
Researchers are starting a new trial at the National Institutes of Health Clinical Center, hoping to find out how to curb the cravings that plague...
“Methadone, buprenorphine, and extended-release naltrexone ... save lives” but most people with OUD get no treatment, new report says.
“Brain power” takes on new meaning with results from a study funded by the National Institute on Alcohol Abuse and Alcoholism.
Despite FDA efforts under Commissioner Scott Gottlieb to raise awareness of teen vaping, only 21% of those surveyed correctly responded that e-...
Integrating Care for Patients With Chronic Liver Disease and Mental Health and Substance Use Disorders
Mental health disorders are common among patients with chronic liver disease, and current literature supports the use of better screening and...
Interventions that target parental use and emphasize positive parenting may lower adolescent opioid use.
BONITA SPRINGS, FLA. – Data suggest that patients often achieve significant improvements by reducing alcohol intake short of abstinence.
New research exposes data that might have overlooked a demographic of women significantly affected by the opioid epidemic....